LY3872386

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3872386, covering 2025-10-03 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]